The Effects of Heart Rate Variability Biofeedback on Functional Gastrointestinal Disorders: A Scoping Review

Ashley G Pereira, Lily Fu, William Xu, Armen Gharibans, Gregory O'Grady
{"title":"The Effects of Heart Rate Variability Biofeedback on Functional Gastrointestinal Disorders: A Scoping Review","authors":"Ashley G Pereira, Lily Fu, William Xu, Armen Gharibans, Gregory O'Grady","doi":"10.1101/2024.07.22.24310788","DOIUrl":null,"url":null,"abstract":"Functional Gastrointestinal Disorders (FGID) are a group of symptom-based disorders that occur across the alimentary tract and have a high prevalence globally in both adults and children. These symptoms are chronic and/or recurrent and often have substantial effects on quality of life. Their incidence is tied to multiple factors, including gut-brain axis imbalance, which includes autonomic dysregulation related to a relative withdrawal of vagal activity. Heart rate variability biofeedback (HRVB) is a non-invasive intervention that can influence autonomic activity and has shown benefit for diverse conditions including depression and anxiety, however the evidence of its effect has not yet been systematically assessed in FGIDs. This scoping review aimed to collate and evaluate the available literature regarding HRVB and FGIDs. We systematically searched four medical databases. Four articles met inclusion criteria for being interventional studies using HRVB in FGIDs. These were heterogeneous, including both paediatric and adult as well different subtypes of FGID. Two of the four studies demonstrated significant improvements from HRVB interventions in FGID symptoms while the other two found no significant difference. Scoping evaluation indicated this inconsistency likely reflects heterogeneous populations and study designs. Further scoping review of the broader HRVB literature also discovered that at least six weeks of HRVB is required to observe an impact on FGID symptoms and defined recommended guidance for performing future evaluations of HRVB in FGIDs. Evidence on HRVB for FGID is emergent, however HRVB appears a promising intervention when administered optimally. Further studies using best-practice techniques are required.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"113 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.07.22.24310788","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Functional Gastrointestinal Disorders (FGID) are a group of symptom-based disorders that occur across the alimentary tract and have a high prevalence globally in both adults and children. These symptoms are chronic and/or recurrent and often have substantial effects on quality of life. Their incidence is tied to multiple factors, including gut-brain axis imbalance, which includes autonomic dysregulation related to a relative withdrawal of vagal activity. Heart rate variability biofeedback (HRVB) is a non-invasive intervention that can influence autonomic activity and has shown benefit for diverse conditions including depression and anxiety, however the evidence of its effect has not yet been systematically assessed in FGIDs. This scoping review aimed to collate and evaluate the available literature regarding HRVB and FGIDs. We systematically searched four medical databases. Four articles met inclusion criteria for being interventional studies using HRVB in FGIDs. These were heterogeneous, including both paediatric and adult as well different subtypes of FGID. Two of the four studies demonstrated significant improvements from HRVB interventions in FGID symptoms while the other two found no significant difference. Scoping evaluation indicated this inconsistency likely reflects heterogeneous populations and study designs. Further scoping review of the broader HRVB literature also discovered that at least six weeks of HRVB is required to observe an impact on FGID symptoms and defined recommended guidance for performing future evaluations of HRVB in FGIDs. Evidence on HRVB for FGID is emergent, however HRVB appears a promising intervention when administered optimally. Further studies using best-practice techniques are required.
心率变异生物反馈对功能性胃肠病的影响:范围综述
功能性胃肠病(FGID)是一组以症状为基础的疾病,发生在整个消化道,在全球成人和儿童中的发病率都很高。这些症状是慢性和/或复发性的,通常对生活质量有很大影响。其发病率与多种因素有关,包括肠脑轴失衡,其中包括与迷走神经活动相对减弱有关的自律神经失调。心率变异性生物反馈疗法(HRVB)是一种非侵入性干预措施,可影响自律神经活动,对包括抑郁症和焦虑症在内的多种疾病均有疗效,但尚未对其在 FGIDs 中的效果进行系统评估。本范围综述旨在整理和评估有关 HRVB 和 FGIDs 的现有文献。我们系统地检索了四个医学数据库。有四篇文章符合纳入标准,即在 FGIDs 中使用 HRVB 进行干预性研究。这些研究内容各不相同,包括儿科和成人以及不同亚型的 FGID。四项研究中有两项研究表明,HRVB干预对FGID症状有明显改善,而另外两项研究则发现没有明显差异。范围界定评估表明,这种不一致性可能反映了不同的人群和研究设计。对更广泛的 HRVB 文献的进一步范围界定审查还发现,至少需要进行六周的 HRVB 才能观察到对 FGID 症状的影响,并确定了未来对 FGID 进行 HRVB 评估的建议指南。有关 HRVB 治疗 FGID 的证据尚不成熟,但如果以最佳方式实施,HRVB 似乎是一种很有前景的干预措施。需要使用最佳实践技术开展进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信